Clinical Trial

Cardiac Sarcoidosis Randomized Trial

Study Description

Cardiac Sarcoidosis Randomized Trial

Prospective randomized controlled trial comparing low dose Prednisone/Methotrexate combination to standard dose Prednisone in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone/Methotrexate combination will be as effective as standard dose Prednisone, and result in significantly better quality of life and less toxicity than standard dose Prednisone.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Prednisone

Oral prednisone tablet

Drug - Methotrexate

Oral, subcutaneous, or intramuscular methotrexate

Additional Information

Official Study Title

Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial

Clinical Trial ID

NCT03593759

ParticipAid ID

en55Wd